Monsenso signs contract with NHS in UK
One of the largest health trusts in the UK, NHS Foundation Trust of Central and North West London, will now implement Danish mobile health (mHealth) from Monsenso to support the treatment of young patients suffering from schizophrenia.
In the future young patients from Kensington, Chelsea, Westminster, Milton Keynes and Hillingdon in north-west London will have access to Danish mHealth.
Monsenso, a Copenhagen-based technology company and member of Welfare Tech, have signed a contract with the NHS Foundation Trust of Central Northwest London (CNWL), one of Great Britain’s largest trust, caring for people with physical and mental health needs. CNWL will implement the Monsenso mobile health (mHealth) solution to support the treatment of young patients suffering from schizophrenia.
The pilot, which will run from July to December 2016, will be implemented amongst young patients aged 18 to 24. It will be the first step prior to rolling out the solution more widely and fully integrating it with TTP SystmOneenabling clinicians to access all patient data from one place.
The objective of the pilot is to evaluate the clinical and economic benefits of using the Monsenso solution such as reducing the number of psychiatric readmissions and using the latest technology to collect and analyse patient data.
- CNWL aims to offer its patients high-quality treatment with the latest technology available. With the implementation of the Monsenso mHealth solution, clinicians will be able to access a patient’s historical aggregated data, which will help them offer a better treatment based on evidence, says Thomas Lethenborg, CEO at Monsenso ApS.
Early detection and better treatment
With the help of the Monsenso mHealth solution, clinicians will be able to identify the triggers and early warning signs of the young patients and intervene at an early stage to avoid emergency situations. The clinical web portal provides clinicians with an insight into the correlation between a patient’s behavioural patterns and the illness enabling them to provide a more informed and better treatment to a larger number of patients.
- We are working closely with our service users, partners, and stakeholders to be more responsive towards people’s needs. The implementation of the Monsenso mHealth solution is part of a wider service redesign to improve our community mental health services across North West London, says Dr Pramod Prabhakaran, Divisional Medical Director of CNWL.
For additional information
Please contact Jennifer Highland, Marketing and Communications Manager, Monsenso, T. +45 8171 7713, firstname.lastname@example.org,
or visit the Monsenso website
Monsenso is member of Welfare Tech.